CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.
Scanning the Horizon Informing Decision-Makers About Emerging Medical Technologies The purpose of this newsletter is to provide information about various sources of publicly accessible horizon scanning information on new and emerging health technologies. The newsletter consolidates a selection of horizon scanning information sources, to help...
This test is for patients who have received a diagnosis of angiomatoid fibrous histiocytoma through conventional histology, to confirm the diagnosis or differential diagnosis of other soft tissue sarcomas. Angiomatoid fibrous histiocytoma is a rare soft-tissue tumour of low or intermediate malignancy that usually occurs in children and you...
Protein C is a vitamin K-dependent glycoprotein that plays an important regulatory role in blood clotting. Sequencing allows for identifying any known or unknown mutation, in contrast to testing one by one for the mutation in question. Given the number of mutations that can be detected, it is not recommended to search for a specific ty...
This test is complementary to other HPV diagnostic and screening procedures. It displays a level of sensitivity and specificity clearly superior to hybrid capture testing. However, no information was found on the relationship between knowledge of the virus type and mortality. Information on this lab test was originally published in French ...
This test measures the enzymatic activity of carbamoyl phosphate synthetase by spectrophotometry. It is for patients with a strong clinical suspicion of carbamoyl phosphate synthetase deficiency, whose othertest results, including those of molecular tests, are ambiguous or inconclusive. Information on this lab test was originally published in F...
The test is performed on a sample of bone tissue obtained from a biopsy. The tissue is analyzed in a pathology laboratory using the RT-PCR method. Information on this lab test was originally published in French by the Institut national d’excellence en santé et en services sociaux (INESSS). CADTH is pleased to provide this translated version. To...
This test is for patients with diabetes who require confirmation of a differential diagnosis of type 1 versus type 2 diabetes. The anti-GAD antibody is a marker that allows confirmation of new-onset type 1 diabetes, confirms autoimmune progression of type 2 diabetes toward type 1, and recognizes the autoimmune etiology of the stiff-man syndrome....